The Higher Education Commission of Pakistan, through its National Academy of Higher Education, has announced a three-day training program on Applied Artificial Intelligence for University ...
ISLAMABAD - Higher Education Commission (HEC) of Pakistan, through its National Academy of Higher Education (NAHE), has announced a pioneering 3-day training programme on “Applied Artificial ...
Higher Education Commission (HEC) of Pakistan, through its National Academy of Higher Education (NAHE), has announced a pioneering 3-day training programme on “Applied Artificial Intelligence for ...
RAS Commander MCP provides bounded, read-only information from HEC-RAS project and plan text through the public RAS Commander Python API. It requires no HEC-RAS executable. The fuller modeling, ...
Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...
The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...
Smoke, fire and chaos greeted new University of Delaware resident assistants Tuesday, but it was all part of hands-on training designed to prepare them for real emergencies inside residence halls. In ...
Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results